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Abstract 
Objective: This systematic review assesses the causal relationship between Mycobacterium avium subspecies 
paratuberculosis (MAP) and Crohn's disease (CD). 
Methods: A systematic review and meta-analysis of some impressive PCR based studies is provided aimed to 
answer among other questions the following question. Is there a cause effect relationship between Mycobacterium 
avium subspecies paratuberculosis and Crohn's disease? The method of the conditio per quam relationship was 
used to proof the hypothesis whether the presence of Mycobacterium avium subspecies paratuberculosis 
guarantees the presence of Crohn's disease. In other words, if Crohn's disease is present, then Mycobacterium 
avium subspecies paratuberculosis is present too. The mathematical formula of the causal relationship k was used 
to proof the hypothesis, whether there is a cause effect relationship between Mycobacterium avium subspecies 
paratuberculosis and Crohn's disease. Significance was indicated by a p-value of less than 0.05. 
Results: The studies analyzed (number of cases and controls N=1076) were able to provide evidence that 
Mycobacterium avium subspecies paratuberculosis is a necessary condition (conditio sine qua non) and sufficient 
condition of Crohn's disease. Furthermore, the studies analyzed provide impressive evidence of a cause-effect 
relationship between Mycobacterium avium subspecies paratuberculosis and Crohn's disease. 
Conclusion: Mycobacterium avium subspecies paratuberculosis is the cause of Crohn's disease (k=+0.4435, p 
value < 0.0001).   
Keywords: Mycobacterium avium subspecies paratuberculosis, Crohn's disease, cause effect relationship, 
causality 
1. Introduction 
Crohn's disease, described in 1904 by Polish surgeon Antoni Leśniowski (Leśniowski, 1904), later in 1913 by 
Dalziel (Dalziel, 1913) and ultimately by Crohn, Ginzburg and Oppenheimer in 1932 (Crohn et al., 1932), is a 
debilitating chronic inflammatory bowel disease (IBD) of unknown cause. Leśniowski-Crohn's disease affects 
about 6.3 per 100,000 people-years in Europe (Burisch, 2015). Many times, the initial signs and symptoms of 
Crohn's disease (CD) are non-specific and can overlap with symptoms of irritable bowel syndrome (IBS). A delay 
in the diagnosis of this inflammatory bowel disease (IBD) is associated with problems for both patients and 
physicians. Often Crohn's disease patients suffer from abdominal pain, malabsorption, steatorrhea, protein losing 
enteropathy, excessive diarrhea, rapid weight loss and other symptoms which may affect their quality of life 
(Danese et el., 2015). Several different extra-intestinal complications of Crohn's disease (events outside the 
gastrointestinal tract) may occur. Lesions of Crohn's disease begin as mucosal erosions and neutrophil infiltrates 
within crypts and crypt abscesses and may progress to transmural lymphogranulomatous enteritis while a 
cobblestoned appearance in the distal ileum and colon is observed in Crohn's disease patients (Greenstein, 2004). 
Medical treatment of Crohn's disease patients includes nutritional therapy, a medication having weak anti-MAP 
activity with anti-inflammatory drugs, immunosuppressants, and sometimes antibiotics too. A view monoclonal 
antibodies such as Adalimumab (Humira ®) and Infliximab (Remicade ®) are used too, to treat Crohn's disease 
patients. Most often, Crohn's disease patients require a dangerous, costly and time-consuming surgical intervention 
(laparoscopy, strictureplasty, anastomosis, bypass surgery et cetera). A number of theories regarding the etiology 
of Crohn's disease are discussed including diet, infections, other unidentified environmental factors, immune 
dysregulation and autoimmune theories. Still, the cause of Crohn's disease or some critical aspects in the 
pathogenesis of this disease are not known. Many authors are of the opinion that Crohn's disease is a syndrome 
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caused by several etiologies. Mycobacterium avium subspecies paratuberculosis (MAP) is endemic in the bovine 
populations of many countries (Chaubey et el., 2017) and known to be a causative agent of Johne's disease, an 
inflammatory bowel disease in a variety of mammals including monkeys, chimpanzees, cattle, sheep, deer, bison 
and other animals. Johne's disease was discovered by Dr. H. A. Johne and Dr. L. Frothingham as visiting scientists 
from the Pathology Unit in Boston, Massachusetts at the Veterinary Pathology Unit in Dresden by investigating 
the tissues of a cow from the Oldenburg region of Germany. The first occurrence of Johne's disease (Pearson, 1908) 
in the U.S. was published by Leonard Pearson (1868-1909) in 1908. The first description of the similarities 
between Crohn's disease and Johne's disease in cattle was made in 1913 by the Scottish surgeon Thomas Kennedy 
Dalziel (Dalziel, 1913). The zoonotic capacities of MAP (Atreya et al., 2014) and the transmission routes to 
humans (Donaghy et al., 2004; Grant et al., 2002) have been discussed in literature widely. Humans are frequently 
exposed to MAP through different transmission routes. In this context, Mycobacterium avium subsp. 
paratuberculosis has been detected in retail cheese in about 31.7% of the samples (Ikonomopoulos et al., 2005). 
Due to the similarities between Johne's disease in cattle and Crohn's disease, it has been argued that Mycobacterium 
avium subspecies paratuberculosis (MAP), which causes Johne's disease, might also be a cause of Crohn's disease 
too. Historically, MAP became the leading infectious candidate as the causative agent of Crohn's disease. 
Meanwhile, the evidence to support a M. paratuberculosis infection as a cause of Crohn's disease is mounting 
rapidly. Studies were able to document that up to 83% of Crohn's patients showed evidence of serum antibodies 
(Elsaghier et al., 1992; Suenaga et al., 1999; El-Zaatari Fet al., 1999; Naser et al., 1999; Naser et al., 2000; Olsen 
et al., 2001) to M. avium ss paratuberculosis. In particular, critics of the mycobacterial theory argue that MAP is 
not a causal factor but a secondary invader (Chamberlin et al., 2006). The relationship between Mycobacterium 
avium subspecies paratuberculosis (M. paratuberculosis) and Crohn's disease is suspected but the evidence remains 
controversial. 
2. Material and Methods 
Chronic diarrhea is not the only but one of the most common presenting symptom of Crohn's disease. Severe 
disease-specific complications of this lifelong disease and a global health problem too are common and 
accompanied by disabling symptoms and impaired quality of life. The need for repeated courses of cost-expensive 
therapies, hospitalization and surgery determines a substantial healthcare burden which affects the patient, the 
healthcare systems and human society in general. 
2.1 Search Strategy 
For the questions addressed in this paper, PubMed was searched for case-control studies conducted in any country 
which investigated the relationship between Mycobacterium avium subspecies paratuberculosis (MAP) and 
Crohn’s disease at least by polymerase chain reaction (PCR). The search in PubMed was performed while using 
medical key words like “case control study” and “Mycobacterium avium subspecies paratuberculosis” and 
“Crohn’s disease” and “PCR DNA” et cetera. The articles found where saved as a *.txt file while using PubMed 
support (Menu: Send to, Choose Radio Button: File, Choose Format: Abstract (text). Click button “create file”). 
The created *.txt file was converted into a *.pdf file. The abstracts where studied within the *.pdf file. Those 
articles were considered for a review which provided access to data without any data access barrier; no data access 
restrictions were accepted. Additionally, references from relevant publications and review articles were checked. 
Case-control studies were included if they compared the prevalence of MAP in patients with Crohn’s disease with 
the prevalence in healthy controls. Studies were excluded if insufficient data were provided to calculate the 
measures of relationship or if there were data access barriers.  
2.2 The Data of the Studies Analyzed 
Mycobacterium avium subspecies paratuberculosis is an obligate intracellular pathogen (Naser et al., 2014) which 
is unable to synthesize mycobactin. MAP requires mycobactin to obtain iron from environmental sources. This is 
one of the reasons why MAP cannot replicate outside of a host. MAP can colonise the host for years without 
causing disease. In point of fact, is very difficult to detect Mycobacterium paratuberculosis using routine culture 
techniques. Many attempts to detect and isolate MAP by culture techniques from Crohn's tissues were unsuccessful. 
M. paratuberculosis recovers very poorly by culture from Crohn's disease tissues while the incubation times 
(sometimes greater than one year) can be extremely long. In this context, MAP DNA can be identified especially 
by PCR. Thus far, novel laboratory techniques (Chae et al., 2017) Southern Blot hybridization, 
Immunohistochemistry (IHC), introduced by Coons (Coons et al., 1941) in 1941, In-situ hybridization (ISH), 
described in the year 1969 by Joseph G. Gall (Gall et al., 1969), Fluorescent ISH (FISH), RNA in situ hybridization 
(RNA ISH), Polymerase chain reaction (PCR), Nested PCR, Quantitative polymerase chain reaction (QPCR) et 
cetera) can improve our understanding of the pathogenesis of Crohn’s diseases. The data of the studies (Sanderson 
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et al., 1992; Fidleret al., 1994; Hulten et al., 2001; Ryan et al., 2002;  Bull et al., 2003; Autschbach et al., 2005; 
Sechi et al., 2005; Romero et al., 2005; Szkaradkiewicz et al., 2007; Kirkwood et al., 2009; Mendoza et al., 2010;  
Tuci et al., 2011; Lee et al., 2011; Nazareth et al., 2015; Timms et al., 2016; Khan et al., 2016; Zamani et al., 2017) 
analyzed, are presented by the table 1 (Table 1). The meaning of the abbreviations at, bt, ct, dt, Nt of table 1 (Table 
1), table 2 (Table 2), table 3 (Table 3), table 4 (Table 4) are explained by a 2 by 2-table (Table 5). 
 
Table 1. The data of the studies considered for a meta-analysis 
 Mycobacterium avium subspecies paratuberculosis  
 Crohn's Disease Healthy control Sample Size 
 MAP+ MAP- MAP+ MAP-  
Study at ct bt dt Nt 
Sanderson et al., 1992 26 14 5 35 80 
Fidler et al., 1994 4 27 0 30 61 
Hulten et al., 2001 7 30 0 22 59 
Ryan et al., 2002 6 9 0 12 27 
Bull et al., 2003 34 3 9 25 71 
Autschbach et al., 2005 22 14 4 73 113 
Sechi et al., 2005 30 5 3 26 64 
Romero et al., 2005 10 2 1 5 18 
Szkaradkiewicz et al., 2007 10 6 1 11 28 
Kirkwood et al., 2009 22 34 6 33 95 
Mendoza et al., 2010 30 0 0 10 40 
Tuci et al., 2011 21 10 11 21 63 
Lee et al., 2011 5 14 0 19 38 
Nazareth et al., 2015 27 13 11 18 69 
Timms et al., 2016 6 15 0 21 42 
Khan et al., 2016 16 53 3 46 118 
Zamani et al., 2017 18 10 6 56 90 
Total events 294 259 60 463 1076 
 
2.3 Statistical Analysis  
All statistical analyses were performed with Microsoft Excel version 14.0.7166.5000 (32-Bit) software (Microsoft 
GmbH, Munich, Germany). In order to simplify the understanding of this article, to increase the transparency for 
the reader and to correct some of the misprints of former publications, several of the following lines are repeated 
word by word and taken from former publications. 
2.3.1 The 2x2 Table 
The 2x2 table in this article is defined (Barukčić, 1989; Barukčić, 1997; Barukčić, 2005; Barukčić, 2006a; Barukčić, 
2006b; Barukčić, 2011a; Barukčić, 2011b; Barukčić, 2012; Barukčić, 2016a; Barukčić, 2016b; Barukčić, 2016c; 
Barukčić, 2016d; Barukčić, 2016e; Barukčić, 2017a; Barukčić, 2017b; Barukčić, 2017c; Barukčić, 2017d; 
Barukčić, 2017e; Barukčić, 2017f; Barukčić, 2017g; Barukčić, 2018a; Barukčić, 2018b; Barukčić, 2018c) in 
general more precisely (Table 5) as follows. 
 
Table 5. The sample space of a contingency table 
  Crohn's disease (Conditioned Bt )  
  Yes = +1 No = +0 Total 
MAP PCR DNA (Condition At ) 
Yes = +1 at bt At 
No = +0 ct dt At 
 Total Bt Bt Nt 
 
In general it is (a+b) = At, (c+d) = At, (a+c) = Bt, (b+d) = Bt and at+bt+ct+dt=Nt. Equally, it is Bt+Bt = At + At = Nt. 
In this context, it is p(at)=p(At Bt), p(At) = p(at)+p(bt) or in other words p(At)= p(At Bt)+p(At Bt) while p(At) 
is not defined as p(at). In the same context, it should be considered that p(Bt) = p(at)+p(ct) = p(At Bt) +p(ct) and 
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equally that p(Bt) = 1- p(Bt) =p(bt)+p(dt). In point of fact, the joint probability of At and Bt is denoted by p(AtBt). 
It is p(at)+p(ct)+p(bt)+p(dt) = 1. These relationships are viewed by the table (Table 6) as follows. 
 
Table 6. The sample space of a contingency table 
  Crohn's disease (Conditioned Bt )  
  Yes = +1 No = +0 Total 
MAP PCR DNA (Condition At ) 
Yes = +1 p(at)  p(bt)  p(At)  
No = +0 p(ct)  p(dt)  p(At)  
 Total p(Bt)  p(Bt)  p(Nt)  
 
2.3.2 Independence 
In the case of independence of At and Bt it is 
(1) 
2.3.3 Sufficient Condition (Conditio Per Quam; Material Conditional) 
The mathematical formula of the sufficient condition relationship (conditio per quam) (Barukčić, 1989; Barukčić, 
1997; Barukčić, 2005; Barukčić, 2006a; Barukčić, 2006b; Barukčić, 2011a; Barukčić, 2011b; Barukčić, 2012; 
Barukčić, 2016a; Barukčić, 2016b; Barukčić, 2016c; Barukčić, 2016d; Barukčić, 2016e; Barukčić, 2017a; 
Barukčić, 2017b; Barukčić, 2017c; Barukčić, 2017d; Barukčić, 2017e; Barukčić, 2017f; Barukčić, 2017g; 
Barukčić, 2018a; Barukčić, 2018b; Barukčić, 2018c)  of a population was defined as 
(2) 
and used to proof the hypothesis: if At then Bt .  
2.2.3 Necessary Condition (Conditio Sine Qua Non) 
The formula of the necessary condition (conditio sine qua non) relationship (Barukčić, 1989; Barukčić, 1997; 
Barukčić, 2005; Barukčić, 2006a; Barukčić, 2006b; Barukčić, 2011a; Barukčić, 2011b; Barukčić, 2012; Barukčić, 
2016a; Barukčić, 2016b; Barukčić, 2016c; Barukčić, 2016d; Barukčić, 2016e; Barukčić, 2017a; Barukčić, 2017b; 
Barukčić, 2017c; Barukčić, 2017d; Barukčić, 2017e; Barukčić, 2017f; Barukčić, 2017g; Barukčić, 2018a; Barukčić, 
2018b; Barukčić, 2018c) was derived as 
 
(3) 
and used to proof the hypothesis: without At no Bt. 
2.2.4 Necessary and Sufficient Condition (Material Biconditional) 
The necessary and sufficient condition relationship (Barukčić, 1989; Barukčić, 1997; Barukčić, 2005; Barukčić, 
2006a; Barukčić, 2006b; Barukčić, 2011a; Barukčić, 2011b; Barukčić, 2012; Barukčić, 2016a; Barukčić, 2016b; 
Barukčić, 2016c; Barukčić, 2016d; Barukčić, 2016e; Barukčić, 2017a; Barukčić, 2017b; Barukčić, 2017c; 
Barukčić, 2017d; Barukčić, 2017e; Barukčić, 2017f; Barukčić, 2017g; Barukčić, 2018a; Barukčić, 2018b; 
Barukčić, 2018c) was defined as  
(4) 
2.3.4 The X² Goodness of Fit Test of a Necessary Condition 
Under conditions where the chi-square (Pearson K, 1900) goodness of fit test cannot be used it is possible to use 
an approximate and conservative (one sided) confidence interval as discussed by Rumke (Rumke, 1975), Louis 
(Louis, 1981), Hanley (Hanley et al., 1983) and Jovanovic (Jovanovic et al., 1997) known as the rule of three.  
2.3.5 The Mathematical Formula of the Causal Relationship k 
The mathematical formula of the causal relationship k (Barukčić, 1989; Barukčić, 1997; Barukčić, 2005; Barukčić, 
2006a; Barukčić, 2006b; Barukčić, 2011a; Barukčić, 2011b; Barukčić, 2012; Barukčić, 2016a; Barukčić, 2016b; 
Barukčić, 2016c; Barukčić, 2016d; Barukčić, 2016e; Barukčić, 2017a; Barukčić, 2017b; Barukčić, 2017c; 
Barukčić, 2017d; Barukčić, 2017e; Barukčić, 2017f; Barukčić, 2017g; Barukčić, 2018a; Barukčić, 2018b; 
Barukčić, 2018c) is defined at every single event, at every single Bernoulli trial t, as 
( ) ( ) ( ) ( ) ( )( ) t t ttt t t t t t t
t
a c d
p A B p A B p A p A B 1 p A 1
N
+ +
→   +   + −   +
( ) ( ) ( )t t t tp A B p A p B  
( ) ( ) ( ) ( ) ( )( ) t t ttt t t t t t t
a b d
p A B p A B p B p A B 1 p B 1
N
+ +
   +   + −   +
( ) ( ) ( ) t tt tt t t t
a d
p A B p A B p A B 1
N
+
   +    +
mhs.ideasspread.org Modern Health Science Vol. 1, No. 1; 2018 
 23 Published by IDEAS SPREAD 
 
 
(5) 
where RUt denotes the cause and 0Wt denotes the effect while the chi-square distribution (Pearson K, 1900) can be 
applied to determine the significance of causal relationship k.  
2.3.6 The Chi Square Distribution 
The chi-squared distribution (Pearson K, 1900) is a widely known distribution and used in hypothesis testing, in 
inferential statistics or in construction of confidence intervals. The critical values of the chi square distribution are 
visualized by Table 8. 
 
Table 8. The critical values of the chi square distribution (degrees of freedom: 1).  
 p-Value Critical one sided X² Critical two sided X² 
 0.1000000000 1.642374415 2.705543454 
 0.0500000000 2.705543454 3.841458821 
 0.0400000000 3.06490172 4.217884588 
 0.0300000000 3.537384596 4.709292247 
The critical values 0.0200000000 4.217884588 5.411894431 
 0.0100000000 5.411894431 6.634896601 
of the 0.0010000000 9.549535706 10.82756617 
 0.0001000000 13.83108362 15.13670523 
Chi square distribution 0.0000100000 18.18929348 19.51142096 
 0.0000010000 22.59504266 23.92812698 
 0.0000001000 27.03311129 28.37398736 
 0.0000000100 31.49455797 32.84125335 
 0.0000000010 35.97368894 37.32489311 
 0.0000000001 40.46665791 41.8214562 
 
3. Results 
3.1 Without the Presence of Mycobacterium Avium Subspecies Paratuberculosis no Presence of Crohn's Disease 
Claims.         
Null hypothesis: The presence of Mycobacterium avium subspecies paratuberculosis is a necessary condition (a 
conditio sine qua non) of Crohn's disease. In other words, the sample distribution agrees with the hypothetical 
(theoretical) distribution of a necessary condition.      
Alternative hypothesis: The presence of Mycobacterium avium subspecies paratuberculosis is not a necessary 
condition (a conditio sine qua non) of Crohn's disease. In other words, the sample distribution does not agree with 
the hypothetical (theoretical) distribution of a necessary condition. The significance level (Alpha) below which the 
null hypothesis will be rejected is alpha=0.05. 
Proof. 
The data reviewed by this article which investigated the relationship between the presence of Mycobacterium avium 
subspecies paratuberculosis and Crohn's disease are viewed by the table (Table 2). Altogether, 17 studies were meta-
analyzed while the level of significance was alpha = 0,05. Altogether, 6 from 17 studies provided significant 
evidence of a conditio sine qua non relationship between Mycobacterium avium subspecies paratuberculosis and 
Crohn's disease. The sample size of the study of Romero et al. (Romero et al., 2005) was small and has been analyzed 
and is significant according to the Rule of three. In the same respect, 17/17 studies analyzed provided evidence of a 
significant cause effect relationship between Mycobacterium avium subspecies paratuberculosis and Crohn's disease. 
In other words, without a Mycobacterium avium subspecies paratuberculosis infection of human intestinal tract no 
Crohn's disease. Due to methodological inconsistencies, 11 of 17 studies reanalyzed failed to provide statistically 
significant evidence of this relationship. In point of fact, the presence of Mycobacterium avium subspecies 
paratuberculosis inside human intestinal tract is a necessary condition (a conditio sine qua non) of Crohn's disease. 
In other words, without the presence of Mycobacterium avium subspecies paratuberculosis inside human intestinal 
tract no Crohn's disease. Q. e. d. 
( )
( ) ( ) ( )( )( )
( ) ( )( ) ( ) ( )( )
R t 0 t R t 0 t
R t 0 t
2
R t 0 tR t 0
p U W p U p W
k U , W
p U p U p W p W
 − 

  
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Table 2. Without MAP infection of human intestinal tract no Crohn’s disease 
Study Id Year Country Nt at bt ct dt p(SINE) X² (SINE) k X²(k) p val (k) 
Mendoza et al., 2010 2010 Spain 40 30 0 0 10 1 0.008333333 1 40 2.53963E-10 
Bull et al., 2003 2003 UK 71 34 9 3 25 0.9577465 0.168918919 0.668723016 31.75052356 1.75302E-08 
Romero et al., 2005 2005 USA 18 10 1 2 5 0.8888889 Rule of three 0.644658371 7.480519481 0.006237007 
Sechi et al., 2005 2005 Italy 64 30 3 5 26 0.921875 0.578571429 0.7507418 36.071248 1.90233E-09 
Tuci et al., 2011 2011 Italy  63 21 11 10 21 0.8412698 2.911290323 0.333669355 7.014120017 0.008086937 
Zamani et al., 2017 2017 Iran 90 18 6 10 56 0.8888889 3.223214286 0.571683803 29.41401341 5.84534E-08 
  Total 346 143 30 30 143 0.9132947 6.890328289  151.7304245  
        Alpha = 0.05  Alpha = 0.05 
   Degrees of freedom (D. f.) = 5  D. f. = 6 
   X² (Critical SINE) = 11.07049769 X² (Critical k)= 12.59158724 
   X² (Calculated SINE)= 6.890328289 X² (Calculated k)= 151.7304245 
           p value (k)= 3.33166E-30 
 
3.2 If Presence of Mycobacterium Avium Subspecies Paratuberculosis then Presence of Crohn's Disease 
Claims. 
Null Hypothesis: The presence of Mycobacterium avium subspecies paratuberculosis is a sufficient condition (a 
conditio per quam) of Crohn's disease. In other words, the sample distribution agrees with the hypothetical 
(theoretical) distribution of a sufficient condition. 
Alternative Hypothesis: The presence of Mycobacterium avium subspecies paratuberculosis is not a sufficient 
condition (a conditio per quam) of Crohn's disease. In other words, the sample distribution does not agree with the 
hypothetical (theoretical) distribution of a sufficient condition. The significance level (Alpha) below which the null 
hypothesis will be rejected is alpha=0.05.               
Proof. 
The data reviewed by this article which investigated the relationship between the presence of Mycobacterium avium 
subspecies paratuberculosis inside human intestinal tract and Crohn's disease are viewed by the table (Table 3). 
Altogether, 17 studies were meta-analyzed with n=1076 number of cases and controls while the level of significance 
was alpha = 0.05. Thus far, 17 out of 17 studies provided significant evidence of a conditio per quam relationship 
between Mycobacterium avium subspecies paratuberculosis and Crohn's disease. The studies of Ryan et al. (Ryan 
et al., 2002), Romero et al. (Romero et al., 2005) and Szkaradkiewicz et al. (Szkaradkiewicz et al., 2007) were 
analyzed and are significant according to the Rule of three. In the same respect, 17/17 studies analyzed provided 
evidence of a significant cause effect relationship between Mycobacterium avium subspecies paratuberculosis and 
Crohn's disease. In other words, if infection of human intestinal tract by Mycobacterium avium subspecies 
paratuberculosis then Crohn's disease. In point of fact, the presence of Mycobacterium avium subspecies 
paratuberculosis within human intestinal tract is a sufficient condition (a conditio per quam) of Crohn's disease. In 
other words, if presence of Mycobacterium avium subspecies paratuberculosis within human intestinal tract then 
presence of Crohn's disease. Q. e. d. 
3.3 Mycobacterium Avium Subspecies Paratuberculosis is Necessary and Sufficient Condition of Crohn's Disease  
Claims.  
Null hypothesis: The presence of Mycobacterium avium subspecies paratuberculosis is a necessary and sufficient 
condition of Crohn's disease. In other words, the sample distribution agrees with the hypothetical (theoretical) 
distribution of a necessary and sufficient condition. 
Alternative Hypothesis: The presence of Mycobacterium avium subspecies paratuberculosis is not a necessary and 
sufficient condition of Crohn's disease. In other words, the sample distribution does not agree with the hypothetical 
(theoretical) distribution of a necessary and sufficient condition. The significance level (Alpha) below which the 
null hypothesis will be rejected is alpha=0.05. 
Proof.  
The data reviewed by this article which investigated the relationship between the presence of Mycobacterium avium 
subspecies paratuberculosis and Crohn's disease are viewed by the table (Table 4). Altogether, in this proof, 17 
studies were meta-analyzed while the level of significance was alpha = 0.05. In toto, 4 studies were able to provide 
significant evidence that Mycobacterium avium subspecies paratuberculosis is a necessary and sufficient condition 
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of Crohn's disease. The study of Romero et al. (Romero et al., 2005) have been analyzed and was significant 
according to the Rule of three. In point of fact, more or less older studies failed to provide evidence of this 
relationship. In the same respect, 17/17 studies analyzed provided evidence of a significant cause effect relationship 
between Mycobacterium avium subspecies paratuberculosis and Crohn's disease and thus far the absence of 
independence. In other words it is true that without the presence of Mycobacterium avium subspecies 
paratuberculosis within human intestinal tract no presence of Crohn's disease and at the same time it is equally true 
that if presence of Mycobacterium avium subspecies paratuberculosis in human intestinal tract then presence of 
Crohn's disease too. In particular, Mycobacterium avium subspecies paratuberculosis is a necessary and sufficient 
condition of Crohn's disease. Q. e. d. 
 
Table 3. If MAP infection then CD 
Study Id Year Country Nt at bt ct dt p(IMP) X²(IMP) k X²(k) p val (k) 
Mendoza et al., 2010 2010 Spain 40 30 0 0 10 1.0000 0.0083 1.0000 40.0000 0.0000000003 
Romero et al, 2005  2005 USA 18 10 1 2 5 0.9444 Rule of three 0.6447 7.4805 0.0062370075 
Szkaradkiewicz et al., 2007 2007 Poland 28 10 1 6 11 0.9643 Rule of three 0.5489 8.4349 0.0036807951 
Hulten et al., 2001 2001 USA 59 7 0 30 22 1.0000 0.0357 0.2829 4.7225 0.0297712403 
Ryan et al., 2002 2002 Geramny 27 6 0 9 12 1.0000 Rule of three 0.4781 6.1714 0.0129829729 
Timms et al., 2016 2016 Australia 42 6 0 15 21 1.0000 0.0417 0.4082 7.0000 0.0081509716 
Lee et al., 2011 2011 Canada 38 5 0 14 19 1.0000 0.0500 0.3892 5.7576 0.0164177087 
Fidler et al., 1994 1994 UK 61 4 0 27 30 1.0000 0.0625 0.2606 4.1426 0.0418165336 
Sechi et al., 2005 2005 Italy 64 30 3 5 26 0.9531 0.1894 0.7507 36.0712 0.0000000019 
Khan et al., 2016 2016 India 118 16 3 53 46 0.9746 0.3289 0.2288 6.1773 0.0129398574 
Autschbach et al., 2005 2005 Geramany 113 22 4 14 73 0.9646 0.4712 0.6190 43.2968 0.0000000000 
Sanderson et al., 1992 1992 UK 80 26 5 14 35 0.9375 0.6532 0.5388 23.2258 0.0000014405 
Kirkwood et al., 2009 2009 Australia 95 22 6 34 33 0.9368 1.0804 0.2579 6.3180 0.0119518827 
Zamani et al., 2017 2017 Iran 90 18 6 10 56 0.9333 1.2604 0.5717 29.4140 0.0000000585 
Bull et al., 2003 2003 UK 71 34 9 3 25 0.8732 1.6802 0.6687 31.7505 0.0000000175 
Nazareth et al., 2015 2015 Portugal 69 27 11 13 18 0.8406 2.9013 0.2934 5.9407 0.0147955514 
Tuci et al., 2011 2011 Italy  63 21 11 10 21 0.8254 3.4453 0.3337 7.0141 0.0080869370 
  
Total 1076 294 60 259 463 0.9442 12.20856 0.4435 272.91802 
 
      
Alpha =0.05 Alpha =0.05       
Degrees of freedom (D. f.) =14 D. f. =17       
X² (Critical IMP) =23.6847913 X² (Critical k)=27.587112       
X² (Calculated IMP)= 12.2085699 X² (Calculated k)=272.91802           
p value (k)=4.229E-48 
 
3.4 Mycobacterium Avium Subspecies Paratuberculosis is the Cause of Crohn's Disease 
Claims. 
Null hypothesis (no causal relationship): There is no significant causal relationship between an infection by 
Mycobacterium avium subspecies paratuberculosis and Crohn's disease. (k=0).  
Alternative hypothesis: (causal relationship): There is a significant causal relationship between an infection by 
Mycobacterium avium subspecies paratuberculosis and Crohn's disease. (k0). Conditions. Alpha level = 5%.   
The two tailed critical Chi square value (degrees of freedom = 1) for alpha level 5% is 3.841458821.   
Proof. 
The data for this hypothesis test were provided by different studies and are illustrated by a table (Table 3). The 
causal relationship k(Mycobacterium avium subspecies paratuberculosis, Crohn's disease) is calculated according 
to Barukčić (Barukčić, 1989; Barukčić, 1997; Barukčić, 2005; Barukčić, 2006a; Barukčić, 2006b; Barukčić, 2011a; 
Barukčić, 2011b; Barukčić, 2012; Barukčić, 2016a; Barukčić, 2016b; Barukčić, 2016c; Barukčić, 2016d; Barukčić, 
2016e; Barukčić, 2017a; Barukčić, 2017b; Barukčić, 2017c; Barukčić, 2017d; Barukčić, 2017e; Barukčić, 2017f; 
Barukčić, 2017g; Barukčić, 2018a; Barukčić, 2018b; Barukčić, 2018c). Again, 17 studies were meta-analyzed with 
n=1076 number of cases and controls while the level of significance was alpha = 0.05. Thus far, all the 17 studies 
analyzed provided evidence of a significant cause effect relationship between Mycobacterium avium subspecies 
paratuberculosis and Crohn's disease. In other words, Mycobacterium avium subspecies paratuberculosis and 
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Crohn's disease are not only not independent of each other. Besides of the methodological difficulties associated 
with the studies analyzed the majority of the studies provided significant evidence of a necessary condition, of a 
sufficient condition and of a necessary and sufficient condition. The conclusion appears to be inescapable: 
Mycobacterium avium subspecies paratuberculosis is the cause of Crohn's disease (k~ +0.4435, p value < 0.0001). 
Q. e. d. 
 
Table 4. MAP infection of human intestinal tract is a necessary and sufficient condition of CD 
Study Id Year Country Nt at bt ct dt p(IMP^SINE) X²(IMP^SINE) k X²(k) p val (k) 
Mendoza et al., 2010 2010 Spain 40 30 0 0 10 1 0.0167 1 40.00 p<0.001 
Romero et al., 2005 2005 USA 18 10 1 2 5 0.833333 Rule of three 0.644658371 7.48 0.0062 
Sechi et al., 2005 2005 Italy 64 30 3 5 26 0.875 0.7680 0.7507418 36.07 p<0.001 
Bull et al., 2003 2003 UK 71 34 9 3 25 0.830985 1.8492 0.668723016 31.75 p<0.001   
Total 193 104 13 10 66 0.880829016 2.6338 
 
107.82 
 
        
Alpha = 0.05 Alpha = 0.05      
Degrees of freedom (D. f.) = 3 D. f. = 3      
X² (Critical IMP^SINE) = 7.8147 X² (Critical k)= 7.81      
X² (Calculated IMP^SINE)= 2.6338 X² (Calculated k)= 107.82           
p value (k)< 0.0001 
 
3.5 Antibiotic Therapy and Crohn's Disease 
One of the most convincing contributions to the evidence of a role for MAP in Crohn’s disease would be a proof 
that a treatment with appropriate antibiotics for sufficient duration able kill the organism leads to remission of 
Crohn’s disease. In this context, different antibiotic drug combinations, called anti-MAP regimen, including 
clarithromycin (CLA), rifabutin (RIF) and Clofazimine (CLO) investigated in multiple randomized clinical trials 
have shown (Grant et al., 1996; Eltholth et al., 2009; Ricchi et al., 2014; Faria et al., 2014; Borody et al., 2002) 
promising results. A complete healing of ulcers in Crohn’s disease patients after more than 6 months of treatment 
with a rifabutin (RIF) and clarithromycin (CLA) regimen, an inhibitor of CYP34A (Akiyoshi et al., 2013), has 
been reported by several studies. A 2007 case study reported that one Crohn's disease patient who was being treated 
with anti-MAP therapy drugs, attained complete clinical remission (Chamberlin et al., 2007). Selby et al. (Selby 
et al., 2007) conducted a prospective, parallel, placebo-controlled, double-blind, randomized treatment trial using 
the combination of clarithromycin, rifabutin, and clofazimine. Two hundred thirteen patients were randomized 
while the study design of the study of Selby et al. (Selby et al., 2007) included an initial 16-week phase in which 
all patients received prednisolone in addition to trial medications. Remission was defined as Crohn’s Disease 
Activity Index < 150. Using combination antibiotic therapy with rifabutin, clarithromycin, and clofazimine Selby 
et al. (Selby et al., 2007) did not find evidence of a sustained benefit for Crohn’s disease patient. At the end of 
week 16 period, there was only “a significantly greater percentage of subjects in remission in the antibiotic arm 
(67/102 [66%]) than in the placebo arm (55/111 [50%]) (P = .02)”. Selby et al. (Selby et al., 2007) concluded that 
their finding does not support a significant contribution of Mycobacterium avium subspecies paratuberculosis in 
the pathogenesis of Crohn’s disease. Thus, what unifies the conclusions of the abovementioned study group (Selby 
et al., 2007) is seemingly the disparate misuse of statistical methods and the data of their study made publicly 
available for further investigations to an extent which demands and justifies several critical remarks. Firstly. The 
inappropriate definition of remission of Crohn’s disease (defined as Crohn’s Disease Activity Index < 150) is 
highly subjective, unfair and has underestimated Crohn’s Disease cases achieved remission. The use of Crohn’s 
Disease Activity Index has overestimated the number of cases in the placebo group which achieved remission. 
Therapeutic monitoring can and should be grounded on objective parameters too like C-reactive protein, 
Erythrocyte sedimentation rate, Procalcitonin (PCT), antibody (Ab) against Mycobacterium avium ssp. 
Paratuberculosis, faecal calprotectin, colonoscopy and other. Secondly. The abovementioned study presented 
contradictory outcomes while at the same time it cannot be excluded that subjects were not exposed to the correct 
dose of drugs. Clofazimine capsules were reencapsulated and it was found that the clofazimine capsules did not 
rupture in vitro. “Because of this, there was a period of approximately 10 months during which it was possible that 
subjects were not exposed to the correct dose of clofazimine.” (Selby et al., 2007). In contrast to Selby et al. (Selby 
et al., 2007), Gui et al. (Gui et al., 1997) treated 46 patients with severe Crohn's disease with rifabutin in 
combination with a macrolide antibiotic (clarithromycin or azithromycin). An improvement in inflammatory 
parameters was observed and the clinical remission based on the Harvey–Bradshaw activity index was induced in 
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43 (93.5%) patients. The studies concerning chemotherapy with antimycobacterial agents have given mixed or 
contradictory results in Crohn’s disease patients. Thus far, a causal relationship between M. paratuberculosis and 
Crohn’s disease derived from chemotherapy studies has not been demonstrated beyond any reasonable doubt.  
4. Discussion 
Mycobacterium avium subspecies paratuberculosis is a robust and phenotypically versatile pathogen which is 
widespread in domestic livestock, present in retail pasteurized cows' milk and potentially, elsewhere. A high-
temperature short-time pasteurization of milk appears not effectively to kill M. paratuberculosis in milk (Grant et 
al., 1998). Even water supplies are also at risk. Mycobacterium avium subspecies paratuberculosis (MAP) has the 
potential to cause chronic inflammation of the intestine in many species, including primates. Crohn's disease has 
long been suspected of having a mycobacterial cause. Still, for many years the role of mycobacteria, specifically 
Mycobacterium paratuberculosis in Crohn's disease has aroused considerable controversy. The inconsistencies 
throughout the studies on the relationship between Mycobacterium paratuberculosis and Crohn's disease are very 
great and due to several factors. First of all, it is known that Mycobacterium paratuberculosis is very difficult to 
be detected by culture and due to the heterogeneous nature of CD the rate of detection of M. avium subsp. 
paratuberculosis in individuals with CD can vary extremely. The development of highly sensitive and M. 
paratuberculosis-specific polymerase chain reaction assays and an appropriate in situ hybridization method is 
highly welcomed. Further technical and methodological advances should allow the identification and/or isolation 
of M. paratuberculosis from a significantly higher proportion of Crohn's disease tissues compared too controls. 
Clinical differences in patients studied, including treatment regimens and the duration of disease are not considered 
in an appropriate manner. Patients studied were analyzed by different methods while the sensitivity of the methods 
used was not determined. In addition to these inconsistencies, the methodological uncertainty surrounding the role 
of Mycobacterium avium subsp paratuberculosis (Map) in Crohn's disease is great. The studies analyzed are full 
of contradictory findings due to small sample size, the lack of uniformity in the materials and methods used by 
many authors and other factors too. Under such circumstances, is it possible at all to provide new and convincing 
perspectives (Singh et al., 2011)? One might argue that in line with problems like these, the question is justified 
whether a decision about a relationship between M. avium subsp. paratuberculosis and Crohn's disease under such 
conditions is possible at all? Still, the extent to which several studies were able to determine a strong and significant 
relationship between Mycobacterium avium subsp. paratuberculosis and Crohn's disease reduces the penumbra of 
uncertainty surrounding the methodological problems of the studies dramatically. The need for such an explanation 
is especially pressing, since some studies provided data which are extraordinary and cannot be ignored.  
 
Table 9. The data of Zamani et al. (Zamani et al., 2017) 
  Crohn’s disease (CD)  
  Yes No Total  
Mycobacterium avium 
subsp. paratuberculosis (MAP) 
Yes 18 6 24  
No 10 56 66  
 Total 28 62 90  
 Results:     
 p(AtBt)= 0.8889  p(At → Bt) =0.93333333 
X²(UW) = 3.223214286  X²( At → Bt) = 1.260416667 
 k(At, Bt) = +0.5717    
 p val (k)= 5.84534E-08    
 
More particularly, according to Zamani et al. (Zamani et al., 2017) Mycobacterium avium subsp. paratuberculosis 
is necessary condition of Crohn's disease and equally a sufficient condition of Crohn's disease while the cause 
effect relationship between Mycobacterium avium subsp. paratuberculosis and Crohn's disease is highly significant. 
The data of are viewed by a 2x2 table (Table 9). In point of fact, i. e. how could Zamani et al. (Zamani et al., 2017) 
provide such an impressive evidence of the relationship between Mycobacterium avium subsp. paratuberculosis 
and Crohn's disease? In toto, 6 of 17 studies analysed using the ultra sensitive polymerase chain reaction (PCR) 
for the detection of M. avium subsp. paratuberculosis within Crohn's disease provided convincing evidence of a 
conditio sine qua non relationship between M. avium subsp. paratuberculosis and Crohn's disease patients. In other 
words, without M. avium subsp. paratuberculosis no Crohn's disease. The involvement of M. avium subsp. 
paratuberculosis in Crohn's disease (CD) in humans has been uncertain because of several substantial difficulties 
especially in detecting this pathogen. Still, even if 11 studies failed on the point aformentioned, the question is 
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how could 6 studies document such an evidence. At the same time, M. avium subsp. paratuberculosis and Crohn's 
disease are causally related. All studies analyzed provide convincing evidence that the presence of M. avium subsp. 
paratuberculosis gurantees the presence of Crohn's disease. In other words, if an infection with M. avium subsp. 
paratuberculosis is present, then Crohn's disease is present too (X² Calculated = 12,2085699 and is less than X² Critical 
= 23,6847913, degrees of freedom = 14). Three studies where analyzed according to the rule of three. At the same 
time, M. avium subsp. paratuberculosis and Crohn's disease were not independent of each other. Additionally, 4 
out of 17 studies were able to provide evidence that M. avium subsp. paratuberculosis is a necessary and sufficient 
condition of Crohn's disease. In this context, 17 of 17 studies provided data which are consistent with the 
conclusion that there is a significant cause and effect relationship between M. avium subsp. paratuberculosis and 
Crohn's disease. Besides of the very limited number of cases and controls studied, the present study confirms 
previous reports of the association between M. avium subsp. paratuberculosis and Crohn's disease. Altogether, the 
results of this study support the hypothesis that M. avium subsp. paratuberculosis is the cause of Crohn's disease 
which implicates the necessity of an effective antibacterial treatment supported by a plant based lactose free diet 
of this mycobacterial intestinal infection. Once questions raised by methodological inconsistencies and their 
difficulty are acknowledged, a treatment of Crohn's disease patients with appropriate antibiotics for sufficient 
duration able kill Mycobacterium avium ssp. paratuberculosis (MAP) is worth being considered. Effective 
treatment of a mycobacterial infection can be difficult, due to the structure of the mycobacterial cell wall. In 
principle, the mycobacterial cell wall can hinder the entry of drugs and is able to make many antibiotics ineffective. 
Mycobacterium avium ssp. paratuberculosis (MAP) as the etiologic agent of cattle's paratuberculosis (Johne's 
disease) lacks its cell wall in humans (Naser et al., 2004) while more than 30 strains (Harris et al., 2001) of MAP 
have been identified. Cell wall deficient bacterial organisms may lack important cell wall antigens more than cell 
wall competent bacterial organisms, and so are less visible to host immune surveillance and theoretically may 
survive better than other organism. The human immune system shaped through evolution by the necessity of 
discriminating non-self pathogens from self tissues and extremely important for the survival of a multicellular 
organisms uses especially antigens to determine which cells are resident and which are foreign. In the following, 
antibodies can recognize an antigen and lock onto it without being capable of destroying it without help. 
Mycobacterium avium ssp. paratuberculosis appears to avoid recognition by the immune system and makes the 
triggering of immune responses against itself to a very great extent ineffective. Parameters like C-reactive protein, 
Erythrocyte sedimentation rate, Procalcitonin (PCT), IgG, IgM, IgA antibodies against Mycobacterium avium ssp. 
paratuberculosis may provide only a weak and approximate picture of the extent of inflammation. In particular, 
using antibiotic drugs which aim to target the cell wall of Mycobacterium avium ssp. paratuberculosis may lead to 
complications, the rise of multidrug resistance bacteria and inhibiting of normal flora. At the end, such a strategy 
could be inefficient for treatment of Crohn’s disease patients. The evidence presented in this study based on a 
systematic review of other studies justify the assumption to treat Crohn’s disease with antibiotic. The following or 
similar Phase I (Table 10) and Phase II (Table 11) drug regimen for the treatment of Crohn’s disease patients is 
still not established. Whether does it makes sense to stop the therapy with Rifaximin 550 mg b.i.d. (i. e. or 
Metronidazol 400 mg b.i.d. and Ciprofloxacin 500 mg b.i.d.) which is used to control intestinal microbiome 
dysbiosis and Predinsolon 60 mg q.d. (in this context used to control clinical symptoms) after two months of 
therapy is another point which is not secured. Diagnostic (or therapeutic) colonoscopy if necessary with the support 
of a feeding / gastroduodenal tube is needed for therapeutic monitoring and to reduce the microflora of the gut 
mechanically. The therapy with drugs free of lactose (a disaccharide composed of galactose and glucose) like 
Clarithromycin 500 mg b. i. d., Rifabutin 450 mg q. d. and Colofazimine 50 mg q. d. should continue for at least 
further 4 months or longer until a complete remission is achieved. Although shortening the duration of therapy is 
a desirable target, the use of the standard 4-month rifabutin-containing regimen or longer is worth being considered. 
Safety evaluation, risk control and therapeutic monitoring should consider at least prameters like C-reactive protein, 
Erythrocyte sedimentation rate, Procalcitonin (PCT), IgG, IgM, IgA antibodies against Mycobacterium avium ssp. 
paratuberculosis, faecal calprotectin and of course other too.  
The novelty of this study is focused on the causal relationship between Crohn’s disease and Mycobacterium avium 
ssp. paratuberculosis. The hypothesis that Mycobacterium paratuberculosis is the cause of Crohn's disease is older 
than 100 years (Dalziel, 1913). In particular, it necessary to emphasized that a lot of the controversy (Van 
Kruiningen, 1999) concerning MAP and CD stems from inconsistent methodology used to detect and isolate MAP, 
which have questioned the causal (Naser et al., 2014) relationship between Crohn's disease (CD) and cell wall-
deficient (CWD) forms of Mycobacterium avium subspecies paratuberculosis (M. paratuberculosis). This study 
has been able to establish a causal link between Mycobacterium avium subspecies paratuberculosis (MAP) and 
Crohn's disease beyond any reasonable doubt. Due to small sample sizes and other factors, arguments to the 
contrary equally have to be considered. Besides of the difficulties mentioned growing evidence determined by all 
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the studies presented suggests that Mycobacterium avium subspecies paratuberculosis is a sufficient condition of 
Crohn's disease. At the same time, all studies provided evidence of a significant cause effect relationship between 
and Mycobacterium avium subspecies paratuberculosis (MAP) and Crohn's disease (k~+0.4435, p value < 0.0001). 
This article provides a review of recent PCR DNA based works on the relationship between and Mycobacterium 
avium subspecies paratuberculosis (MAP) and Crohn's disease and invites us to consider the following inescapable 
conclusion. 
 
Table 10. Phase I. The starting 2 months antibiotic regimen to treat MAP in Crohn’s disease 
Week 1 2 3 4 5 6 7 8 
Predinsolon 60 mg q.d. (x)  (x)  (x)  (x)  
Rifaximin 550 mg b.i.d. x  x  x  x  
Probiotics / 25 OH Vitamin D3 …  x  x  x  x 
(diagnostic or therapeutic) 
colonoscopy 
 x  x  x  x 
Furthermore:         
Colofazimine 50 mg q.d. x x x x x x x x 
Clarithromycin 500 mg b.i.d. x x x x x x x x 
Rifabutin 450 mg q.d. x x x x x x x x 
 
Table 11. Phase II. The 4 months and longer antibiotic regimen to treat MAP in Crohn’s disease 
Month 3 4 5 6 7 8 9 10 
Colofazimine 50 mg q.d. x x x x x x x … 
Clarithromycin 500 mg b.i.d. x x x x x x x … 
Rifabutin 450 mg q.d. x x x x x x x … 
(diagnostic or therapeutic) 
colonoscopy 
x (x) (x) x (x) (x) x … 
Probiotics / 25 OH Vitamin D3 … x   x   x  
 
5. Conclusion 
In this review, data has been presented in the form of tables providing evidence for a cause effect relationship 
between MAP and CD by PCR. Based on this information, Mycobacterium avium subspecies paratuberculosis 
(MAP) is definitively the cause of Crohn's disease. Consequently, the need for more sophisticated and optimized 
antibiotic therapy is required so that CD patient can be cured accurately and definitely.  
Acknowledgements 
During  the  years  1982-1989  I  studied  human  medicine  at  the  University  of  Hamburg (Germany) 
and completed and concluded the studies of human medicine in the year 1989 with a final state examination 
(Ärztliche Prüfung). In the year 1984/1985 I started my PhD investigations at the department of internal medicine 
(headed by Prof. Dr. Heiner Greten) at the Universitätskrankenhaus Eppendorf, Hamburg with the thesis Crohn’s 
disease/Ulcerative colitis under the supervision of Prof. Dr. Eberhard Windler. Meanwhile, more than 30 years 
later and in accordance with the German saying “Was lange währt, wird endlich gut” (‘all good things are worth 
waiting for’), this job is done. 
References 
Akiyoshi, T., It,o M., Murase, S., Miyazaki, M., Guengerich, F. P., Nakamura, K., Yamamoto, K., & Ohtani, H. 
(2013). Mechanism-based inhibition profiles of erythromycin and clarithromycin with cytochrome P450 3A4 
genetic variants. Drug Metabolism and Pharmacokinetics, 28, 411-415. 
https://doi.org/10.2133/dmpk.DMPK-12-RG-134 
Atreya, R., Bülte, M., Gerlach, G. F., Goethe, R., Hornef, M. W., Köhler, H., … Weiss, S. (2014). Facts, myths 
and hypotheses on the zoonotic nature of Mycobacterium avium subspecies paratuberculosis. International 
Journal of Medical Microbiology, 304, 858-867. https://doi.org/10.1016/j.ijmm.2014.07.006  
Autschbach, F., Eisold, S., Hinz, U., Zinser, S., Linnebacher, M., Giese, T., Löffler, T., Büchler, M. W., & Schmidt, 
J. (2005). High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues 
from individuals with Crohn's disease. Gut, 54, 944-949. https://doi.org/10.1136/gut.2004.045526 
mhs.ideasspread.org Modern Health Science Vol. 1, No. 1; 2018 
 30 Published by IDEAS SPREAD 
 
Barukčić K, Barukčić, I. (2016b) Epstein Barr Virus - The Cause of Multiple Sclerosis. Journal of Applied 
Mathematics and Physics, 4, 1042-53. https://doi.org/10.4236/jamp.2016.46109  
Barukčić, I. (1989). Die Kausalität. Hamburg: Wissenschaftsverlag, pp. 218. 
Barukčić, I. (1997). Die Kausalität. Wilhelmshaven: Scientia, 1997. pp. 374.  
Barukčić, I. (2005). Causality. New Statistical Methods. Hamburg - Norderstedt: Books on Demand, pp. 488. 
Barukčić, I. (2006a). Causality. New Statistical Methods, Second English Edition. Hamburg-Norderstedt: Books 
on Demand, pp. 488.  
Barukčić, I. (2006b). New method for calculating causal relationships. Proceeding of XXIIIrd International 
Biometric Conference. July 16-21; McGill University, Montréal, Québec, Canada. p. 49. 
Barukčić, I. (2011a). Causality I. A Theory of Energy, Time and Space. Morrisville: Lulu, pp. 648. 
Barukčić, I. (2011a). Causality II. A Theory of Energy, Time and Space. Morrisville: Lulu, pp. 376. 
Barukčić, I. (2012). The deterministic relationship between cause and effect. International International Biometric 
Conference, Kobe, JAPAN, 26 - 31 August 2012. https://www.biometricsociety.org/conference-
abstracts/2012/programme/p1-5/P-1/249-P-1-30.pdf  
Barukčić, I. (2016a). The Mathematical Formula of the Causal Relationship k. International Journal of Applied 
Physics and Mathematics, 6, 45-65. https://doi.org/10.17706/ijapm.2016.6.2.45-65 
Barukčić, I. (2016c). Unified Field Theory. Journal of Applied Mathematics and Physics, 4, 1379-1438. 
https://doi.org/10.4236/jamp.2016.48147 
Barukčić, I. (2016d). Epstein-Barr Virus (Ebv) – a Main Cause of Rheumatoid Arthritis. viXra, 7, 1-5. 
http://vixra.org/abs/1612.0361 
Barukčić, I. (2016e). Epstein Bar Virus (Ebv) - A Cause of Human Breast Cancer. viXra, 7, 1-29. 
http://vixra.org/abs/1701.0325  
Barukčić, I. (2017a). Helicobacter pylori-The Cause of Human Gastric Cancer. Journal of Biosciences and 
Medicines, 5, 1-19. https://doi.org/10.4236/jbm.2017.52001 
Barukčić, I. (2017b). Anti Bohr - Quantum Theory and Causality. International Journal of Applied Physics and 
Mathematics, 7, 93-111. https://doi.org/10.17706/ijapm.2017.7.2.93-111 
Barukčić, I. (2017c). Theoriae causalitatis principia mathematica. Hamburg - Norderstedt: Books on Demand, pp. 
244. https://www.bod.de/buchshop/theoriae-causalitatis-principia-mathematica-ilija-barukcic-
9783744815932 
Barukčić, I. (2017d). Human papilloma virus - A cause of malignant melanoma, viXra, 8, 1-13. 
http:///vixra.org/abs/1710.0311 
Barukčić, I. (2017e). Human Papillomavirus - A cause of human prostate cancer. viXra, 8, 1-57. 
http://vixra.org/abs/1711.0437  
Barukčić, I. (2017f). Human Papillomavirus - The cause of human cervical cancer. viXra, 8, 1-56. 
http://vixra.org/abs/1711.0339  
Barukčić, I. (2017g). Helicobacter pylori is the cause of human gastric cancer. viXra, 8, 1-50. 
http://vixra.org/abs/1712.0018  
Barukčić, I. (2018a). Parvovirus B19 the Cause of Systemic Sclerosis. viXra, 9, 1-28. 
http://vixra.org/abs/1801.0423 
Barukčić, I. (2018b). Epstein Bar Virus—The Cause of Hodgkin’s Lymphoma. Journal of Biosciences and 
Medicines, 6, 75-100. https://doi.org/10.4236/jbm.2018.61008 
Barukčić, I. (2018c). Fusobacterium nucleatum—The Cause of Human Colorectal Cancer. Journal of Biosciences 
and Medicines, 6, 31-69. http://dx.doi.org/10.4236/jbm.2018.63004 
Borody, T. J., Leis, S., Warren, E. F., & Surace, R. (2002). Treatment of severe Crohn's disease using 
antimycobacterial triple therapy--approaching a cure? Digestive and Liver Disease, 34, 29-38. 
https://doi.org/10.1016/S1590-8658(02)80056-1 
Bull, T. J., McMinn, E. J., Sidi-Boumedine, K., Skull, A., Durkin, D., Neild, P., Rhodes, G., Pickup, R., & Hermon-
Taylor, J. (2003). Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh 
mhs.ideasspread.org Modern Health Science Vol. 1, No. 1; 2018 
 31 Published by IDEAS SPREAD 
 
ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. Journal of Clinical 
Microbiology, 41, 2915-2923. https://dx.doi.org/10.1128/JCM.41.7.2915-2923.2003 
Burisch, J., & Munkholm, P. (2015). The epidemiology of inflammatory bowel disease. Scandinavian Journal of 
Gastroenterology, 50, 942-951. https://doi.org/10.3109/00365521.2015.1014407 
Chae, Y. K., Arya, A., Chiec, L., Shah, H., Rosenberg, A., Patel, S., Raparia, K., Choi, J., … Giles, F. (2017). 
Challenges and future of biomarker tests in the era of precision oncology: Can we rely on 
immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for 
matched therapy? Oncotarget, 8, 100863-100898. https://doi.org/10.18632/oncotarget.19809 
Chamberlin, W. M., & Naser, S. A. (2006). Integrating theories of the etiology of Crohn's disease. On the etiology 
of Crohn's disease: questioning the hypotheses. Medical Science Monitor, 12, RA27-33. 
https://www.medscimonit.com/download/index/idArt/445257  
Chamberlin, W., Ghobrial, G., Chehtane, M., & Naser, S. A. (2007). American Journal of Gastroenterology, 102, 
689-691. https://doi.org/10.1111/j.1572-0241.2007.01040_7.x 
Chaubey, K. K., Singh, S. V., Gupta, S., Singh, M., Sohal, J. S., Kumar, N., … Dhama, K. (2017). Mycobacterium 
avium subspecies paratuberculosis - an important food borne pathogen of high public health significance with 
special reference to India: an update. The Veterinary Quarterly, 37, 282-299. 
https://doi.org/10.1080/01652176.2017.1397301 
Coons, A. H., Creech, H. J., & Jones, R. N. (1941). Immunological Properties of an Antibody Containing a 
Fluorescent Group. Experimental Biology and Medicine, 47, 200-202. https://doi.org/10.3181/00379727-47-
13084p 
Crohn, B. B., Ginzburg, L., & Oppenheimer, G. D. (1932). Regional ileitis: A pathologic and clinical entity. Journal 
of the American Medical Association, 99, 1323-1329. https://doi.org/10.1001/jama.1932.02740680019005 
Dalziel, T. K. (1913). Chronic Interstitial enteritis. British Medical Journal, 2, 1068-1070. 
Danese, S., Fiorino, G., Mary, J. Y., Lakatos, P. L., D'Haens, G., Moja, L., D'Hoore, A., … Colombel, J. F. (2015). 
Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of 
Crohn's Disease: An IOIBD Initiative. Journal of Crohn's and Colitis, 9, 601-606. 
https://doi.org/10.1093/ecco-jcc/jjv067 
Donaghy, J. A., Totton, N. L., & Rowe, M. T. (2004). Persistence of Mycobacterium paratuberculosis during 
manufacture and ripening of cheddar cheese. Applied and Environmental Microbiology, 70, 4899-4905. 
https://dx.doi.org/10.1128/AEM.70.8.4899-4905.2004 
Elsaghier, A., Prantera, C., Moreno, C., & Ivanyi, J. (1992). Antibodies to Mycobacterium paratuberculosis-
specific protein antigens in Crohn's disease. Clinical and Experimental Immunology, 90, 503-508. 
https://doi.org/10.1111/j.1365-2249.1992.tb05874.x 
Eltholth, M. M., Marsh, V. R., Van Winden, S., & Guitian, F. J. (2009). Contamination of food products with 
Mycobacterium avium paratuberculosis: a systematic review. Journal of Applied Microbiology, 107, 1061-
1071. https://doi.org/10.1111/j.1365-2672.2009.04286.x 
El-Zaatari, F. A., Naser, S. A., Hulten, K., Burch, P., & Graham, D. Y. (1999). Characterization of Mycobacterium 
paratuberculosis p36 antigen and its seroreactivities in Crohn's disease. Current Microbiology, 39, 115-119. 
https://doi.org/10.1007/s002849900430 
Faria, A. C., Schwarz, D. G., Carvalho, I. A., Rocha, B. B., De Carvalho, Castro, K. N., Silva, M. R., & Moreira, 
M. A. (2014). Short communication: Viable Mycobacterium avium subspecies paratuberculosis in retail 
artisanal Coalho cheese from Northeastern Brazil. Journal of Dairy Science, 97, 4111-4114. 
https://doi.org/10.3168/jds.2013-7835 
Fidler, H. M., Thurrell, W., Johnson, N. M., Rook, G. A., & McFadden, J. J. (1994). Specific detection of 
Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease. Gut, 35, 506-
510. http://dx.doi.org/10.1136/gut.35.4.506 
Gall, J. G., & Pardue, M. L. (1969). Formation and detection of RNA-DNA hybrid molecules in cytological 
preparations. Proceedings of the National Academy of Sciences of the United States of America, 63, 378-83. 
Grant, I. R., Ball, H. J., & Rowe, M. T. (1998). Effect of high-temperature, short-time (HTST) pasteurization on 
milk containing low numbers of Mycobacterium paratuberculosis. Letters in Applied Microbiology, 26, 166-
170. http://doi.org/10.1046/j.1472-765X.1998.00309.x 
mhs.ideasspread.org Modern Health Science Vol. 1, No. 1; 2018 
 32 Published by IDEAS SPREAD 
 
Grant, I. R., Ball, H. J., & Rowe, M. T. (2002). Incidence of Mycobacterium paratuberculosis in bulk raw and 
commercially pasteurized cows' milk from approved dairy processing establishments in the United Kingdom. 
Applied and Environmental Microbiology, 68, 2428-2435. https://doi.org/10.1128/AEM.68.5.2428-2435.20 
Grant, I. R., Ball, H. J., Neill, S. D., & Rowe, M. T. (1996). Inactivation of Mycobacterium paratuberculosis in 
cows' milk at pasteurization temperatures. Applied and Environmental Microbiology, 62, 631-636. 
http://aem.asm.org/content/62/2/631 
Greenstein, R. J., & Collins, M. T. (2004). Emerging pathogens: is Mycobacterium avium subspecies 
paratuberculosis zoonotic? The Lancet, 364, 396-397. https://doi.org/10.1016/S0140-6736(04)16781-0  
Gui, G. P., Thomas, P. R., Tizard, M. L., Lake, J., Sanderson, J. D., & Hermon-Taylor, J. (1997). Two-year-
outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. The Journal of 
Antimicrobial Chemotherapy, 39, 393-400. https://doi.org/10.1093/jac/39.3.393  
Hanley, J. A., & Lippman-Hand, A. (1983). If Nothing Goes Wrong, Is Everything All Right? The Journal of the 
American Medical Association, 249, 1743-1745. http://doi.org/10.1001/jama.1983.03330370053031 
Harris, N. B., & Barletta, R. G. (2001). Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine. 
Clinical Microbiology Reviews, 14, 489-512. https://doi.org/10.1128/CMR.14.3.489-512.2001 
Hulten, K., El-Zimaity, H. M., Karttunen, T. J., Almashhrawi, A., Schwartz, M. R., Graham, D. Y., & El-Zaatari, 
F. A. (2001). Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by 
in situ hybridization. The American Journal of Gastroenterology, 96, 1529-1535. 
https://doi.org/10.1111/j.1572-0241.2001.03751.x 
Ikonomopoulos, J., Pavlik, I., Bartos, M., Svastova, P., Ayele, W. Y., … Gazouli, M. (2005). Detection of 
Mycobacterium avium subsp. paratuberculosis in retail cheeses from Greece and the Czech Republic. Applied 
and Environmental Microbiology, 71, 8934-8936. https://doi.org/10.1128/AEM.71.12.8934-8936.2005 
Jovanovic, B. D., & Levy, P. S. (1997). A Look at the Rule of Three. The American Statistician, 51, 137-139. 
http://doi.org/10.1080/00031305.1997.10473947 
Khan, I. A., Pilli, S., Surendranath, A., Rampal, R., Chauhan, S. K., Tiwari, V., … Ahuja, V. (2016). Prevalence 
and Association of Mycobacterium avium subspecies paratuberculosis with Disease Course in Patients with 
Ulcero-Constrictive Ileocolonic Disease. PLoS One, 11, 1-11. https://doi.org/10.1371/journal.pone.0152063 
Kirkwood, C. D., Wagner, J., Boniface, K., Vaughan, J., Michalski, W. P., Catto-Smith, A. G., Cameron, D. J., & 
Bishop, R. F. (2009). Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's 
disease. Inflammatory Bowel Diseases, 15, 1643-1655. https://doi.org/10.1002/ibd.20967 
Lee, A., Griffiths, T. A., Parab, R. S., King, R. K., Dubinsky, M. C., … Rioux, K. P. (2011). Association of 
Mycobacterium avium subspecies paratuberculosis with Crohn Disease in pediatric patients. Journal of 
Pediatric Gastroenterology and Nutrition, 52, 170-174. https://doi.org/10.1097/MPG.0b013e3181ef37ba 
Leśniowski, A. (1904). Pamiętnik Towarzystwa Lekarskiego Warszawskiego. Polish Surgeon, 100, 630-631. 
Louis, T. A. (1981). Confidence Intervals for a Binomial Parameter after Observing No Successes. The American 
Statistician, 35, 154. http://doi.org/10.1080/00031305.1981.10479337 
Mendoza, J. L., San-Pedro, A., Culebras, E., Cíes, R., Taxonera, C., Lana, R., Urcelay, E., de la Torre, F., Picazo, 
J. J., & Díaz-Rubio, M. (2010). High prevalence of viable Mycobacterium avium subspecies paratuberculosis 
in Crohn's disease. World Journal of Gastroenterology, 28, 4558-4563. 
http://dx.doi.org/10.3748/wjg.v16.i36.4558 
Naser, S. A., Ghobrial, G., Romero, C., & Valentine, J. F. (2004). Culture of Mycobacterium avium subspecies 
paratuberculosis from the blood of patients with Crohn's disease. Lancet, 364, 1039-1044. 
https://doi.org/10.1016/S0140-6736(04)17058-X 
Naser, S. A., Hulten, K., Shafran, I., Graham, D. Y., & El-Zaatari, F. A. (2000). Specific seroreactivity of Crohn's 
disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis. Veterinary Microbiology, 
77, 497-504. https://doi.org/10.1016/S0378-1135(00)00334-5 
Naser, S. A., Sagramsingh, S. R., Naser, A. S., & Thanigachalam, S. (2014). Mycobacterium avium subspecies 
paratuberculosis causes Crohn's disease in some inflammatory bowel disease patients. World J. Gastroenterol, 
20, 7403-15. https://doi.org/10.3748/wjg.v20.i23.7403  
Naser, S., Shafran, I., & El-Zaatari, F. (1999). Mycobacterium avium subsp. paratuberculosis in Crohn's disease is 
mhs.ideasspread.org Modern Health Science Vol. 1, No. 1; 2018 
 33 Published by IDEAS SPREAD 
 
serologically positive. Clinical and Diagnostic Laboratory Immunology, 6, 282. 
http://cvi.asm.org/content/6/2/282.long 
Nazareth, N., Magro, F., Machado, E., Ribeiro, T. G., Martinho, A., Rodrigues, P., Alves, R., Macedo, G. N., Gracio, 
D., Coelho, R., Abreu, C., Appelberg, R., Dias, C., Macedo, G., Bull, T., & Sarmento, A. (2015). Prevalence 
of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with 
inflammatory bowel disease. Medical Microbiology and Immunology, 204, 681-692. 
https://doi.org/10.1007/s00430-015-0420-3 
Olsen, I., Wiker, H. G., Johnson, E., Langeggen, H., & Reitan, L. J. (2001). Elevated antibody responses in patients 
with Crohn's disease against a 14-kDa secreted protein purified from Mycobacterium avium subsp. 
paratuberculosis. Scandinavian Journal of Immunology, 53, 198-203. https://doi.org/10.1046/j.1365-
3083.2001.00857.x 
Pearson, K. (1896). VII. Mathematical contributions to the theory of evolution.- III. Regression, heredity, and 
panmixia. Philosophical Transactions of the Royal Society of London. Series A, 187, 253-18. 
https://doi.org/10.1098/rsta.1896.0007 
Pearson, K. (1904). Mathematical contributions to the theory of evolution. - XIII. On the Theory of Contingency 
and Its Relation to Association and Normal Correlation. London, Dulau and Co., 1904. pp. 1-35. 
https://archive.org/details/cu31924003064833 
Pearson, K., (1900). On the Criterion That a Given System of Deviations from the Probable in the Case of a 
Correlated System of Variables Is Such That It Can Be Reasonably Supposed to Have Arisen from Random 
Sampling. Philosophical Magazine Series, 5, 157-175. http://dx.doi.org/10.1080/14786440009463897 
Pearson, L. (1908). A note on the occurrence in America of chronic bacterial dysentery of cattle. American 
Veterinary Reviews, 32, 602-605. 
Ricchi, M., De Cicco, C., Kralik, P., Babak, V., Boniotti, M. B., Savi, R., … Arrigoni, N. (2014). Evaluation of 
viable Mycobacterium avium subsp. paratuberculosis in milk using peptide-mediated separation and 
Propidium Monoazide qPCR. FEMS Microbiology Letters, 356, 127-133. https://doi.org/10.1111/1574-
6968.12480 
Romero, C., Hamdi, A., Valentine, J. F., & Naser, S. A. (2005). Evaluation of surgical tissue from patients with 
Crohn's disease for the presence of Mycobacterium avium subspecies paratuberculosis DNA by in situ 
hybridization and nested polymerase chain reaction. Inflammatory Bowel Diseases, 11, 116-125. 
https://dx.doi.org/10.1097/00054725-200502000-00004 
Rumke, C. L. (1975). Implications of the Statement: No Side Effects Were Observed. The New England Journal 
of Medicine, 292, 372-373. http://doi.org/10.1056/NEJM197502132920723 
Ryan, P., Bennett, M. W., Aarons, S., Lee, G., Collins, J. K., O'Sullivan, G. C., O'Connell, J., & Shanahan, F. 
(2002). PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser 
capture microdissection. Gut, 51, 665-670. http://dx.doi.org/10.1136/gut.51.5.665 
Sanderson, J. D., Moss, M. T., Tizard, M. L., & Hermon-Taylor, J. (1992). Mycobacterium paratuberculosis DNA 
in Crohn's disease tissue. Gut, 33, 890-896. http://dx.doi.org/10.1136/gut.33.7.890 
Sechi, L. A., Scanu, A. M., Molicotti, P., Cannas, S., Mura, M., Dettori, G., Fadda, G., & Zanetti, S. (2005). 
Detection and Isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal 
biopsies of patients with and without Crohn's disease in Sardinia. The American Journal of Gastroenterology, 
100, 1529-1536. https://doi.org/10.1111/j.1572-0241.2005.41415.x 
Selby, W., Pavli, P., Crotty, B., Florin, T., Radford-Smith, G., Gibson, P., … Hetzel, D. (2007). Antibiotics in 
Crohn's Disease Study Group. (2007) Two-year combination antibiotic therapy with clarithromycin, rifabutin, 
and clofazimine for Crohn's disease. Gastroenterology, 132, 2313-2319. 
https://doi.org/10.1053/j.gastro.2007.03.031 
Singh, S., & Gopinath, K. (2011). Mycobacterium avium subspecies Paratuberculosis and Crohn's Regional Ileitis: 
How Strong is Association? Journal of Laboratory Physicians, 3, 69-74. https://dx.doi.org/10.4103%2F0974-
2727.86836 
Suenaga, K., Yokoyama, Y., Nishimori, I., Sano, S., Morita, M., Okazaki, K., & Onishi, S. (1999). Serum 
antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease. Digestive Diseases and 
Sciences, 44, 1202-1207. https://doi.org/10.1023/A:1026692627460 
mhs.ideasspread.org Modern Health Science Vol. 1, No. 1; 2018 
 34 Published by IDEAS SPREAD 
 
Suenaga, K., Yokoyama, Y., Okazaki, K., & Yamamoto, Y. (1995). Mycobacteria in the intestine of Japanese 
patients with inflammatory bowel disease. Am J Gastroenterol, 90, 76-80. 
https://www.ncbi.nlm.nih.gov/pubmed/7801954  
Szkaradkiewicz, A., Chudzicka-Strugala, I., Zwozdziak, B., Marciniak, R., Wasilewska, A., & Drews, M. (2007). 
Mycobacterium avium subsp. paratuberculosis w nieswoistych chorobach zapalnych jelit. Przeglad 
Epidemiologiczny, 61, 85-90. Retrieved form http://www.przeglepidemiol.pzh.gov.pl/przeglad-
epidemiologiczny-artykuly?year=2007&perp=10&p=1&sort=asc 
Timms, V. J., Daskalopoulos, G., Mitchell, H. M., & Neilan, B. A. (2016). The Association of Mycobacterium 
avium subsp. paratuberculosis with Inflammatory Bowel Disease. PLoS One, 11, 1-12. 
https://doi.org/10.1371/journal.pone.0148731 
Tuci, A., Tonon, F., Castellani, L., Sartini, A., Roda, G., Marocchi, M., … Belluzzi, A. (2011). Fecal detection of 
Mycobacterium avium paratuberculosis using the IS900 DNA sequence in Crohn's disease and ulcerative 
colitis patients and healthy subjects. Digestive Diseases and Sciences, 56, 2957-2962. 
https://doi.org/10.1007/s10620-011-1699-6 
Van Kruiningen, H. J. (1999). Lack of support for a common etiology in Johne's disease of animals and Crohn's 
disease in humans. Inflamm. Bowel. Dis., 5, 183-91. https://www.ncbi.nlm.nih.gov/pubmed/10453375 
Zamani, S., Zali, M. R., Aghdaei, H. A., Sechi, L. A., Niegowska, M., Caggiu, E., … Feizabadi, M. M. (2017). 
Mycobacterium avium subsp. paratuberculosis and associated risk factors for inflammatory bowel disease in 
Iranian patients. Gut Pathogens, 9, 1-10. https://doi.org/10.1186/s13099-016-0151-z 
 
Copyrights 
Copyright for this article is retained by the author(s), with first publication rights granted to the journal. 
This is an open-access article distributed under the terms and conditions of the Creative Commons Attribution 
license (http://creativecommons.org/licenses/by/4.0/). 
 
